Interview: Kyrexa launches £1.5m funding round for revolutionary Rimcazole canine cancer treatment
Dr Clare Knottenbelt, CEO of Kyrexa, discusses how the company is advancing canine cancer treatment with Rimcazole.
The post Interview: Kyrexa launches £1.5m funding round for revolutionary Rimcazole canine cancer treatment appeared first on Innovation News Network.
Jack Thomas
Quero saber mais sobre como ter sucesso no mundo digital

